<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04861597</url>
  </required_header>
  <id_info>
    <org_study_id>2021-12896</org_study_id>
    <nct_id>NCT04861597</nct_id>
  </id_info>
  <brief_title>Digital Behavioral Interventions in Inflammatory Bowel Disease</brief_title>
  <official_title>Digital Behavioral Interventions in Inflammatory Bowel Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Montefiore Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Montefiore Medical Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Given the bidirectionality between psychological distress and disease activity in&#xD;
      inflammatory bowel disease (IBD), whereby increased psychological distress exacerbates&#xD;
      disease activity and vice versa, psychosocial aspects of IBD care are receiving increased&#xD;
      attention. However, proposed interventions are generally resource-intensive and have been&#xD;
      tested in majority white populations. While people of color are an increasing segment of the&#xD;
      IBD population, they are currently underrepresented in research studies. The purpose of this&#xD;
      study is to evaluate the efficacy and implementation of internet-based cognitive behavioral&#xD;
      therapy (iCBT) among IBD patients of color with elevated psychological distress.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators propose a 1:1 randomized trial design to evaluate the efficacy of iCBT&#xD;
      among a population of Black and Latinx IBD patients and to assess factors influencing its&#xD;
      implementation. Patients within the integrated health system at Montefiore Medical Center&#xD;
      will be actively recruited and screened to identify those with elevated psychological&#xD;
      distress.&#xD;
&#xD;
      Eligible patients will be randomized to receive 8 weeks of iCBT or digital mood tracking to&#xD;
      evaluate the effect of iCBT on levels of psychological distress, HRQoL and disease activity&#xD;
      post-intervention. The investigators will also evaluate individual process level barriers and&#xD;
      facilitators to iCBT implementation via surveys and semi-structured interviews.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2021</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">April 27, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Anxiety and/or depression</measure>
    <time_frame>8 weeks post-intervention</time_frame>
    <description>Level of psychological distress measured by the sub-score domains of anxiety and/or depression on the National Institutes of Health Patient Reported Outcomes Measurement Information System-29 assessment tool (minimum score 4, maximum score 20; higher scores indicate higher anxiety or depression).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Perceived Stress Score</measure>
    <time_frame>8 weeks post-intervention</time_frame>
    <description>Level of perceived stress as measured by the National Institutes of Health Perceived Stress Scale (minimum 14, maximum 75; higher scores indicate higher perceived stress)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health-related Quality-of-Life</measure>
    <time_frame>8 weeks post-intervention</time_frame>
    <description>Health-related Quality-of-Life as measured by the overall National Institutes of Health Patient Reported Outcomes Measurement Information System-29</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Crohn's Disease Activity</measure>
    <time_frame>8 weeks post-intervention</time_frame>
    <description>Measured by Short Crohn's Disease Activity Index in individuals with Crohn's disease (minimum 0, maximum 600; higher scores indicate more disease activity)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ulcerative Colitis Disease Activity</measure>
    <time_frame>8 weeks post-intervention</time_frame>
    <description>Measured by partial Mayo Score (minimum 0, maximum 6; higher score indicates more disease activity) in individuals with ulcerative colitis</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Crohn Disease</condition>
  <condition>Ulcerative Colitis</condition>
  <condition>Inflammatory Bowel Diseases</condition>
  <condition>Stress, Psychological</condition>
  <condition>Depression, Anxiety</condition>
  <arm_group>
    <arm_group_label>Internet-based cognitive behavioral therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Digital mood tracking</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Internet based cognitive behavioral therapy</intervention_name>
    <description>Participants with elevated psychological distress will receive 8 weeks of internet-based cognitive behavioral therapy</description>
    <arm_group_label>Internet-based cognitive behavioral therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Digital mood tracking</intervention_name>
    <description>Participants with elevated psychological distress will receive 8 weeks of digital mood tracking</description>
    <arm_group_label>Digital mood tracking</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age â‰¥ 18 years&#xD;
&#xD;
          -  race/ethnicity self-identified as Black/African American or Hispanic/Latino&#xD;
&#xD;
          -  established diagnosis of Crohn's disease or ulcerative colitis&#xD;
&#xD;
          -  elevated psychological distress: at least one T-score within two standard deviations&#xD;
             above the mean in the domains of anxiety or depression on the National Institutes of&#xD;
             Health Patient Reported Outcomes Measurement Information System-29 (PROMIS-29) with or&#xD;
             without a T-score within two standard deviations above the mean for perceived stress&#xD;
             on the National Institute of Health Toolbox Perceived Stress Scale (Perceived Stress&#xD;
             Scale)&#xD;
&#xD;
          -  internet access (smartphone/mobile device with data plan, computer with internet)&#xD;
&#xD;
          -  ability to provide informed consent in English or Spanish&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  PROMIS-29 anxiety or depression T-scores in the severe range (above 2 standard&#xD;
             deviations)&#xD;
&#xD;
          -  Current suicidal ideation, past suicidal attempt or hospitalization&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ruby Greywoode, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Montefiore Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>K. Zoe Tsagaris</last_name>
    <phone>718-430-8804</phone>
    <email>zoe.tsagaris@einsteinmed.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ruby Greywoode, MD</last_name>
    <phone>347-671-2811</phone>
    <email>rgreywoode@montefiore.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Montefiore Hutchinson Campus</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10461</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ruby Greywoode, MD</last_name>
      <phone>347-671-8205</phone>
      <email>rgreywoode@montefiore.org</email>
    </contact>
    <contact_backup>
      <last_name>Rebecca Almonte</last_name>
      <phone>347-671-8216</phone>
      <email>rebecca.almonte@einsteinmed.org</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Gracie DJ, Guthrie EA, Hamlin PJ, Ford AC. Bi-directionality of Brain-Gut Interactions in Patients With Inflammatory Bowel Disease. Gastroenterology. 2018 May;154(6):1635-1646.e3. doi: 10.1053/j.gastro.2018.01.027. Epub 2018 Jan 31.</citation>
    <PMID>29366841</PMID>
  </reference>
  <reference>
    <citation>Mikocka-Walus A, Knowles SR, Keefer L, Graff L. Controversies Revisited: A Systematic Review of the Comorbidity of Depression and Anxiety with Inflammatory Bowel Diseases. Inflamm Bowel Dis. 2016 Mar;22(3):752-62. doi: 10.1097/MIB.0000000000000620. Review.</citation>
    <PMID>26841224</PMID>
  </reference>
  <reference>
    <citation>Mikocka-Walus A, Bampton P, Hetzel D, Hughes P, Esterman A, Andrews JM. Cognitive-behavioural therapy has no effect on disease activity but improves quality of life in subgroups of patients with inflammatory bowel disease: a pilot randomised controlled trial. BMC Gastroenterol. 2015 May 2;15:54. doi: 10.1186/s12876-015-0278-2.</citation>
    <PMID>25934170</PMID>
  </reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>April 12, 2021</study_first_submitted>
  <study_first_submitted_qc>April 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 27, 2021</study_first_posted>
  <last_update_submitted>November 4, 2021</last_update_submitted>
  <last_update_submitted_qc>November 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Crohn Disease</mesh_term>
    <mesh_term>Colitis, Ulcerative</mesh_term>
    <mesh_term>Intestinal Diseases</mesh_term>
    <mesh_term>Inflammatory Bowel Diseases</mesh_term>
    <mesh_term>Stress, Psychological</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

